Cancer Research UK logo.
SearchDonate
  • Search

A study looking at helping women stay on hormone therapy after breast cancer (SWEET)

Overview

Cancer types:

Breast cancer

Status:

Closed

Phase:

Other

Details

This study is looking at a support package to help women to continue taking their after having breast surgery. The team hope that use of the support package will help women to keep taking their hormone therapy as recommended by their doctors, and improve their wellbeing ().

It is open to women who have breast cancer and have been prescribed:

  • tamoxifen

  • letrozole

  • anastrozole

  • exemestane

  • any other

Recruitment start: 26 March 2024

Recruitment end: 26 September 2025

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Linda Sharp

Professor Eila Watson

Supported by

NIHR Programme Grants for Applied Research (PGfAR)

Newcastle upon Tyne Hospitals NHS Foundation Trust

Newcastle University

Warwick Clinical Trials Unit

Breast Cancer Now

University College London

Other information

The study team have a public website at https://www.sweetstudy.co.uk/.

Last reviewed: 14 Nov 2025

CRUK internal database number: 19521

Help and support